Literature DB >> 29997956

A predictor for mitral valve repair in patient with rheumatic heart disease: the bending angle of anterior mitral leaflet.

Jin-Tao Fu1, Mohammad Sharif Popal1, Yu-Qing Jiao1, Hai-Bo Zhang1, Shuai Zheng1, Qiu-Ming Hu1, Wei Han1, Xu Meng1.   

Abstract

BACKGROUND: Mobility and flexibility of anterior mitral leaflet (AML) are considered to be the important factor for mitral valve (MV) repair in rheumatic population, we try to use the bending angle of AML to quantify its' mobility and flexibility and investigate whether it can predict the success of rheumatic MV repair or not.
METHODS: Total 54 patients underwent rheumatic MV surgeries with mild lesions of subvalvular apparatus from August, 2017 to November, 2017 at the author institution, we divided the patients into MV repair and MV replacement groups which included directly MV replacement and repair attempt but failed repairing transfer to replacement intraoperatively. Patients' MV structure was carefully evaluated on transthoracic echocardiography (TTE) and scored by the Wilkins score (WS) preoperatively. The bending angle of AML was measured during systole and diastole at different level before surgery.
RESULTS: The differences of patients' demographic characteristics between repair group and replacement group were not statistically significant (P value >0.05) and the differences among B-angle, T-angle, Bs-angle, C-angle of AML between repair group and replacement groups were not statistically significant (P value >0.05). Only BT-angle in repair group was significantly larger than that of replacement group (21.56°±3.84°, 10.29°±6.02°, respectively, P<0.001), therefore the BT-angle was tested as a predictor of reparability by observing the receiver operating characteristic (ROC) curve (ROC area: 0.944, standard error: 0.06, 95% CI: 0.826-1), BT-angle of AML on preoperative transthoracic echo of 15.5° or more predicts feasibility of rheumatic MV repair with 100% sensitivity and 85.7% specificity in patients with mild lesions of subvalvular apparatus. Logistic regression for a single area of calcification (diameter <0.8 cm) at commissure were shown that: β: 0.08, Exp (β): 1.083, P: 0.777>0.05, the minor single calcified area at commissure had no effect on reparability of rheumatic MV disease. The differences of total WS and each component score between repair group and replacement group were not statistically significant (P value >0.05). By observing the ROC curve for total WS (ROC area: 0.508), the WS cannot be a predictor for the rheumatic MV repair.
CONCLUSIONS: The bending angle of AML which was considered as quantification of mobility and flexibility of AML can be a predictor for MV repair in patients with rheumatic heart disease (RHD). The small single area of commissural calcification had no effect on reparability of rheumatic MV disease. WS cannot appropriately predict the outcome of rheumatic MV repair.

Entities:  

Keywords:  Predictor; angle of anterior mitral leaflet (AML); mitral valve (MV) repair; rheumatic heart disease (RHD)

Year:  2018        PMID: 29997956      PMCID: PMC6006126          DOI: 10.21037/jtd.2018.05.26

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  24 in total

Review 1.  Update on rheumatic heart disease.

Authors:  Bobby Yanagawa; Jagdish Butany; Subodh Verma
Journal:  Curr Opin Cardiol       Date:  2016-03       Impact factor: 2.161

2.  Balloon mitral valvuloplasty in the United States: a 13-year perspective.

Authors:  Apurva O Badheka; Neeraj Shah; Abhijit Ghatak; Nileshkumar J Patel; Ankit Chothani; Kathan Mehta; Vikas Singh; Nilay Patel; Peeyush Grover; Abhishek Deshmukh; Sidakpal S Panaich; Ghanshyambhai T Savani; Vipulkumar Bhalara; Shilpkumar Arora; Ankit Rathod; Harit Desai; Saibal Kar; Carlos Alfonso; Igor F Palacios; Cindy Grines; Theodore Schreiber; Charanjit S Rihal; Raj Makkar; Mauricio G Cohen; William O'Neill; Eduardo de Marchena
Journal:  Am J Med       Date:  2014-05-20       Impact factor: 4.965

3.  2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Rick A Nishimura; Catherine M Otto; Robert O Bonow; Blase A Carabello; John P Erwin; Lee A Fleisher; Hani Jneid; Michael J Mack; Christopher J McLeod; Patrick T O'Gara; Vera H Rigolin; Thoralf M Sundt; Annemarie Thompson
Journal:  J Am Coll Cardiol       Date:  2017-03-15       Impact factor: 24.094

4.  Mitral valve repair for rheumatic mitral regurgitation: Mid-term results.

Authors:  Somchai Waikittipong
Journal:  Asian Cardiovasc Thorac Ann       Date:  2015-03-17

5.  Subvalvular apparatus and adverse outcome of balloon valvotomy in rheumatic mitral stenosis.

Authors:  Parag Bhalgat; Shrivallabh Karlekar; Santosh Modani; Ashish Agrawal; Charan Lanjewar; Ashish Nabar; Prafulla Kerkar; Nandu Agrawal; Pradeep Vaideeswar
Journal:  Indian Heart J       Date:  2015-08-08

6.  Percutaneous balloon dilatation of the mitral valve: an analysis of echocardiographic variables related to outcome and the mechanism of dilatation.

Authors:  G T Wilkins; A E Weyman; V M Abascal; P C Block; I F Palacios
Journal:  Br Heart J       Date:  1988-10

7.  Predictors of Very Late Events After Percutaneous Mitral Valvuloplasty in Patients With Mitral Stenosis.

Authors:  Elisabete Jorge; Manuel Pan; Rui Baptista; Miguel Romero; Soledad Ojeda; Javier Suárez de Lezo; Henrique Faria; João Calisto; Pedro Monteiro; Mariano Pêgo; José Suárez de Lezo
Journal:  Am J Cardiol       Date:  2016-04-06       Impact factor: 2.778

8.  Echocardiographic evaluation of mitral durability following valve repair in rheumatic mitral valve disease: impact of Maze procedure.

Authors:  Gwan Sic Kim; Chee Hoon Lee; Joon Bum Kim; Sung-Ho Jung; Suk Jung Choo; Cheol Hyun Chung; Jae Won Lee
Journal:  J Thorac Cardiovasc Surg       Date:  2012-11-21       Impact factor: 5.209

9.  Long-term outcomes after surgery for rheumatic mitral valve disease: valve repair versus mechanical valve replacement.

Authors:  Joon Bum Kim; Hee Jung Kim; Duk Hwan Moon; Sung Ho Jung; Suk Jung Choo; Cheol Hyun Chung; Hyun Song; Jae Won Lee
Journal:  Eur J Cardiothorac Surg       Date:  2009-12-24       Impact factor: 4.191

10.  A meta-analysis of late outcomes of mitral valve repair in patients with rheumatic heart disease.

Authors:  Jin-Tao Fu; Mohammad Sharif Popal; Hai-Bo Zhang; Wei Han; Qiu-Ming Hu; Xu Meng; Chun-Ye Ma
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

View more
  4 in total

1.  Mitral valve repair in children with rheumatic heart disease.

Authors:  Srirup Chatterjee; Nikhil Bansal; Rajarshi Ghosh; Lakshmi Kumari Sankhyan; Sujoy Chatterjee; Santosh Pandey; Satyajit Bose
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2020-03-25

Review 2.  Mechanics of the Tricuspid Valve-From Clinical Diagnosis/Treatment, In-Vivo and In-Vitro Investigations, to Patient-Specific Biomechanical Modeling.

Authors:  Chung-Hao Lee; Devin W Laurence; Colton J Ross; Katherine E Kramer; Anju R Babu; Emily L Johnson; Ming-Chen Hsu; Ankush Aggarwal; Arshid Mir; Harold M Burkhart; Rheal A Towner; Ryan Baumwart; Yi Wu
Journal:  Bioengineering (Basel)       Date:  2019-05-22

Review 3.  The "Cairo Accord"- Towards the Eradication of RHD: An Update.

Authors:  Susy Kotit; David I W Phillips; Ahmed Afifi; Magdi Yacoub
Journal:  Front Cardiovasc Med       Date:  2021-07-02

4.  Comparison of Mitral Valve Repair versus Replacement for the Progression of Functional Tricuspid Regurgitation.

Authors:  Yang Gao; Shubin Li; Xijing Zhuang; Feng Gao; Lei Shi; Xu Meng
Journal:  Ann Thorac Cardiovasc Surg       Date:  2019-09-06       Impact factor: 1.520

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.